Rabbit anti-Human ERO1A Polyclonal Antibody

Beta LifeScience SKU/CAT #: BLC-02191A
Western blot | All lanes: ERO1L antibody at 1.25μg/ml | Lane 1: A431 whole cell lysate | Lane 2: 293T whole cell lysate | Secondary | Goat polyclonal to rabbit IgG at 1/10000 dilution | Predicted band size: 54 kDa | Observed band size: 54, 25 kDa
Western blot | All lanes: ERO1L antibody at 1.25μg/ml | Lane 1: A431 whole cell lysate | Lane 2: 293T whole cell lysate | Secondary | Goat polyclonal to rabbit IgG at 1/10000 dilution | Predicted band size: 54 kDa | Observed band size: 54, 25 kDa
Immunohistochemistry of paraffin-embedded human small intestine tissue using ERO1A Antibody at dilution of 1:100
Immunohistochemistry of paraffin-embedded human small intestine tissue using ERO1A Antibody at dilution of 1:100
Immunohistochemistry of paraffin-embedded human pancreatic tissue using ERO1A Antibody at dilution of 1:100
Immunohistochemistry of paraffin-embedded human pancreatic tissue using ERO1A Antibody at dilution of 1:100

Rabbit anti-Human ERO1A Polyclonal Antibody

Beta LifeScience SKU/CAT #: BLC-02191A
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.

Product Overview

Product Title Rabbit anti-Human ERO1A Polyclonal Antibody
Description The antibody against ERO1A was raised in rabbit using the Recombinant Human ERO1-like protein alpha protein (24-260AA) as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, WB, IHC.
Uniprot Id - Alink Q96HE7
Host Species Rabbit
Reactivity Human
Target Name ERO1A
Target Synonyms Endoplasmic oxidoreductin 1 like protein antibody; Endoplasmic oxidoreductin-1-like protein antibody; Endoplasmic reticulum oxidoreductase 1 alpha antibody; Endoplasmic reticulum oxidoreductin 1-like antibody; ERO1 alpha antibody; ERO1 L antibody; ERO1 Lalpha antibody; ERO1 like protein alpha antibody; ERO1-alpha antibody; ERO1-L antibody; ERO1-L-alpha antibody; ERO1-like (S. cerevisiae) antibody; ERO1-like alpha antibody; ERO1-like protein alpha antibody; ERO1-like; S. cerevisiae; homolog of; alpha antibody; ERO1A antibody; ERO1A_HUMAN antibody; ERO1L antibody; ERO1LA antibody; Oxidoreductin 1 Lalpha antibody; Oxidoreductin-1-L-alpha antibody; PRO865 antibody; UNQ434 antibody
Immunogen Description Recombinant Human ERO1-like protein alpha protein (24-260AA)
Immunogen Species Human
Immunogen Sequence Complete sequences for the immunogen, target protein, and peptides are available upon request.
Conjugate Non-conjugated
Clonality Polyclonal
Isotype IgG
Purification Method Antigen affinity purified
Buffer PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Form Liquid
Application ELISA, WB, IHC
Storage Conditions Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

FAQs

Please fill out the Online Inquiry form located on the product page. Key product information has been pre-populated. You may also email your questions and inquiry requests to sales1@betalifesci.com. We will do our best to get back to you within 4 business hours.

Feel free to use the Chat function to initiate a live chat. Our customer representative can provide you with a quote immediately.

Proteins are sensitive to heat, and freeze-drying can preserve the activity of the majority of proteins. It improves protein stability, extends storage time, and reduces shipping costs. However, freeze-drying can also lead to the loss of the active portion of the protein and cause aggregation and denaturation issues. Nonetheless, these adverse effects can be minimized by incorporating protective agents such as stabilizers, additives, and excipients, and by carefully controlling various lyophilization conditions.

Commonly used protectant include saccharides, polyols, polymers, surfactants, some proteins and amino acids etc. We usually add 8% (mass ratio by volume) of trehalose and mannitol as lyoprotectant. Trehalose can significantly prevent the alter of the protein secondary structure, the extension and aggregation of proteins during freeze-drying process; mannitol is also a universal applied protectant and fillers, which can reduce the aggregation of certain proteins after lyophilization.

Our protein products do not contain carrier protein or other additives (such as bovine serum albumin (BSA), human serum albumin (HSA) and sucrose, etc., and when lyophilized with the solution with the lowest salt content, they often cannot form A white grid structure, but a small amount of protein is deposited in the tube during the freeze-drying process, forming a thin or invisible transparent protein layer.

Reminder: Before opening the tube cap, we recommend that you quickly centrifuge for 20-30 seconds in a small centrifuge, so that the protein attached to the tube cap or the tube wall can be aggregated at the bottom of the tube. Our quality control procedures ensure that each tube contains the correct amount of protein, and although sometimes you can't see the protein powder, the amount of protein in the tube is still very precise.

To learn more about how to properly dissolve the lyophilized recombinant protein, please visit Lyophilization FAQs.

Recently viewed